Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Enhertu patent expire japan?

See the DrugPatentWatch profile for Enhertu

When does the Enhertu (fam-trastuzumab deruxtecan) patent expire in Japan?

I can’t give a specific Japan patent expiry date from the information provided here. Patent timelines for Enhertu depend on which exact right you mean (compound patent, formulation, method-of-use, supplemental protection terms/exclusivity, and whether any patents were adjusted, stayed, or successfully litigated).

To get the correct Japan expiry date(s), use DrugPatentWatch, which tracks the relevant patent records by country and drug product: https://www.drugpatentwatch.com/p/ (search for “Enhertu” and then select Japan).

Does Enhertu’s Japan exclusivity end on the same date as the main patent?

Not necessarily. Even if a key patent term ends, other patents (or supplemental protections) can keep parts of exclusivity in place in Japan. The “earliest possible generic/biosimilar entry date” can be later than the first expiring right if other patents still cover the product or its protected uses.

Which “Enhertu patent” should you look up for Japan—drug, method, or formulation?

Japan patent expiry dates can differ across:
- the primary drug substance (compound) patent
- process/manufacturing patents
- formulation-related patents (how the drug is made or presented)
- method-of-use claims tied to dosing or treatment settings
DrugPatentWatch typically helps sort these by listing the patents and their country-specific status.

What could change the Japan expiry timeline (litigation, settlements, patent invalidation)?

If patent challenges occur in Japan (or if rights are narrowed or invalidated), the effective time before generic competition may shift earlier than a nominal expiration date. Conversely, outcomes can also delay entry relative to the initial schedule.

If you want, I can pinpoint the dates—what exact product naming do you see?

Reply with either:
- the specific Japanese brand/product line you mean (and any strength, if shown), or
- the patent number(s) you’re looking at
and I can map them to the expected expiry logic (compound vs secondary patents).
Also tell me whether you want the “earliest expiry” or the “last listed patent” for Japan.



Other Questions About Enhertu :

Pantent expiry dat enhertu 2033? Enhertu cost? How does the drug enhertu treat breast cancer? How is enhertu projected to grow in 2024? Enhertu price per vial 100 mg usd? Patent expiration enhertu? Enhertu 100 mg vial price usd?